PL377180A1 - Zastosowanie izoflawonów i ich pochodnych w leczeniu mukopolisacharydoz - Google Patents

Zastosowanie izoflawonów i ich pochodnych w leczeniu mukopolisacharydoz

Info

Publication number
PL377180A1
PL377180A1 PL377180A PL37718005A PL377180A1 PL 377180 A1 PL377180 A1 PL 377180A1 PL 377180 A PL377180 A PL 377180A PL 37718005 A PL37718005 A PL 37718005A PL 377180 A1 PL377180 A1 PL 377180A1
Authority
PL
Poland
Prior art keywords
mucopolysaccharidoses
isoflavones
derivatives
treatment
Prior art date
Application number
PL377180A
Other languages
English (en)
Inventor
Grzegorz Grynkiewicz
Grzegorz Węgrzyn
Barbara Szechner
Wiesław Szeja
Anna Tylki-Szymańska
Alicja Węgrzyn
Joanna Jakóbkiewicz-Banecka
Sylwia Barańska
Barbara Czartoryska
Ewa Piotrowska
Original Assignee
Instytut Farmaceutyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Farmaceutyczny filed Critical Instytut Farmaceutyczny
Priority to PL377180A priority Critical patent/PL377180A1/pl
Priority to US12/067,289 priority patent/US8178609B2/en
Priority to PCT/PL2006/000064 priority patent/WO2007035121A2/en
Priority to EP06799603A priority patent/EP1968570A2/en
Publication of PL377180A1 publication Critical patent/PL377180A1/pl
Priority to US13/433,492 priority patent/US8623910B2/en
Priority to US14/107,055 priority patent/US20140107051A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL377180A 2005-09-21 2005-09-21 Zastosowanie izoflawonów i ich pochodnych w leczeniu mukopolisacharydoz PL377180A1 (pl)

Priority Applications (6)

Application Number Priority Date Filing Date Title
PL377180A PL377180A1 (pl) 2005-09-21 2005-09-21 Zastosowanie izoflawonów i ich pochodnych w leczeniu mukopolisacharydoz
US12/067,289 US8178609B2 (en) 2005-09-21 2006-09-21 Isoflavones for treating mucopolysaccharidoses
PCT/PL2006/000064 WO2007035121A2 (en) 2005-09-21 2006-09-21 Isoflavones for treating mucopolysaccharidoses
EP06799603A EP1968570A2 (en) 2005-09-21 2006-09-21 Isoflavones for treating mucopolysaccharidoses
US13/433,492 US8623910B2 (en) 2005-09-21 2012-03-29 Isoflavones for treating mucopolysaccharidoses
US14/107,055 US20140107051A1 (en) 2005-09-21 2013-12-16 Isoflavones for treating mucopolysaccharidoses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL377180A PL377180A1 (pl) 2005-09-21 2005-09-21 Zastosowanie izoflawonów i ich pochodnych w leczeniu mukopolisacharydoz

Publications (1)

Publication Number Publication Date
PL377180A1 true PL377180A1 (pl) 2007-04-02

Family

ID=37561221

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377180A PL377180A1 (pl) 2005-09-21 2005-09-21 Zastosowanie izoflawonów i ich pochodnych w leczeniu mukopolisacharydoz

Country Status (4)

Country Link
US (2) US8178609B2 (pl)
EP (1) EP1968570A2 (pl)
PL (1) PL377180A1 (pl)
WO (1) WO2007035121A2 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849257B2 (en) 2000-02-04 2005-02-01 Children's Hospital Research Foundation Lipid hydrolysis therapy for atherosclerosis and related diseases
US20090297496A1 (en) * 2005-09-08 2009-12-03 Childrens Hospital Medical Center Lysosomal Acid Lipase Therapy for NAFLD and Related Diseases
AU2008348372A1 (en) * 2008-01-24 2009-07-30 Gilead Palo Alto, Inc. ALDH-2 inhibitors in the treatment of addiction
FI3205351T3 (fi) 2010-04-23 2023-07-06 Alexion Pharma Inc Lysosomaalisen kertymätaudin entsyymi
KR20150038636A (ko) 2010-09-09 2015-04-08 시나게바 바이오파르마, 코포레이션 환자에서 리소좀 산 리파제 결핍증의 치료를 위한 리소좀 산 리파제의 용도
US9279082B2 (en) * 2011-01-20 2016-03-08 Merck Patent Gmbh Polymerisable compounds and the use thereof in liquid-crystal displays
WO2012112681A1 (en) 2011-02-15 2012-08-23 Shire Human Genetic Therapies, Inc. Methods for treating lysosomal acid lipase deficiency
PL399467A1 (pl) * 2012-06-08 2013-12-09 3G Therapeutics Inc. Zastosowanie genisteiny do obnizania poziomu zwiazków organicznych spichrzanych w komórkach w leczeniu i/lub zapobieganiu lizosomalnych chorób spichrzeniowych (LChS)
US11426406B2 (en) 2017-02-09 2022-08-30 Georgetown University Compositions and methods for treating lysosomal storage disorders
CN110857291B (zh) * 2018-08-24 2021-01-26 中国农业科学院北京畜牧兽医研究所 一种减缓瘤胃微生物分解氨基酸和尿素的天然化合物及其用途
WO2023052579A1 (en) * 2021-09-30 2023-04-06 Universität Regensburg Isoflavone derivatives modulating mutant bestrophin 1 for treatment of best1-related retinopathies
IT202200007808A1 (it) 2022-04-20 2023-10-20 Luigi Michele Pavone Composizioni terapeutiche per malattie causate da accumulo di eparan solfato

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000037072A1 (en) * 1998-12-22 2000-06-29 Alcon Laboratories, Inc. Use of inhibitors of gag synthesis for the treatment of corneal haze

Also Published As

Publication number Publication date
US8623910B2 (en) 2014-01-07
US20090062380A1 (en) 2009-03-05
US20120190642A1 (en) 2012-07-26
WO2007035121A3 (en) 2007-08-02
EP1968570A2 (en) 2008-09-17
US8178609B2 (en) 2012-05-15
WO2007035121A2 (en) 2007-03-29

Similar Documents

Publication Publication Date Title
IL192053A (en) 2-Admentiluria derivatives as selective inhibitors of 1hsd-β11 and their use in drug preparation
IL189578A0 (en) Pyridine derivatives and their use in the treatment of psychotic disorders
DK1917246T3 (da) Benzoquinazolinderivater og deres anvendelse til behandling af knoglesygdomme
SI2084151T1 (sl) Substituirani dihidropirazoloni za zdravljenje kardiovaskularnih in hematoloških bolezni
MA29039B1 (fr) Dibenzylamines et derives
IL199151A (en) Pyrimidine derivatives, their pharmaceutical preparations, their use in cancer treatment and their kits
IL188031A0 (en) Use of thiazole derivatives and analogues in the treatment of cancer
IL177216A0 (en) Benzamide derivatives and their use as glucokinase activating agents
CR8037A (es) Derivados de 2- acilamino- 4- feniletiazol, su preparacion y su aplicacion en terapeutica
SI2046324T1 (sl) Zdravljenje in preventiva mukozitisa z derivati antocianidina
NO20055204D0 (no) Derivater av piperidinyl- og pipemzinylalkylkarbamater, fremgangsmater for fremstilling derav og anvendelse av de samme i terapi
IL180078A (en) Derivatives of 9-cis retinal for use in treating deficiency of 11-cis retinal
DE602005021918D1 (de) Endloskörper und raupenvorrichtung
IS8329A (is) Kínólínafleiður og notkun þeirra í meðferð
AP2006003820A0 (en) Piperazin derivatives and their use in controllingpests
PL377180A1 (pl) Zastosowanie izoflawonów i ich pochodnych w leczeniu mukopolisacharydoz
NO20070892L (no) Sammensetninger av N-glykolylneuraminsyre og anvendelse derav ved behandling av forkjølelse.
DK1773796T3 (da) Oxopiperidinderivater, fremstilling deraf samt terapeutisk anvendelse deraf
ATE420081T1 (de) Trifluormethylbenzamidderivate und therapeutische verwendungen dafür
HRP20150320T1 (xx) Formulacije i metode za lijeäśenje amiloidoze
SI1858481T1 (sl) Oftalmološki sestavki in njihova uporaba
DK1885716T3 (da) Thiazolderivater og anvendelse deraf
EP1864783A4 (en) BONDED BODY AND METHOD OF BONDING
PL1828137T3 (pl) 4-cykloalkilo-podstawione pochodne tetrahydrochinoliny i ich zastosowanie jako leki
DE602006005246D1 (de) Pyridoä2,3-düpyrimidin-derivate sowie deren herstellung und therapeutische anwendung

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)